News & Analysis as of

Health law-news Professional Practice

Read need-to-know updates, commentary, and analysis on Health issues written by leading professionals.
Verrill

Recent FinCEN Advisory Highlights Rising Health Care Fraud Risk for Financial Institutions

Verrill on

As the federal government intensifies its “whole of government” approach to combat fraud, waste, and abuse, particularly in Federal Health Care Benefit Programs, financial institutions face growing exposure to health care...more

McDermott+

McDermott+ Check-Up: April 10, 2026

McDermott+ on

Both the House and Senate have been in recess for the last two weeks. While lawmakers have been out of town, focus has remained on funding the US Department of Homeland Security....more

Seyfarth Shaw LLP

The Week in Weed: April 2026 #2

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we begin in Idaho, where the legislature is not on board with a medical marijuana ballot initiative. Then...more

Jenner & Block

OSHA Announces Enforcement Stay for COVID-19 Recordkeeping and Reporting Obligations

Jenner & Block on

On March 31, 2026, the Occupational Safety and Health Administration (OSHA) published a memorandum updating its enforcement policy for COVID-19 recording and reporting obligations. Specifically, the agency announced that it...more

Jackson Lewis P.C.

Beyond Undergrad: DOJ’s Medical School Investigations Broaden Higher‑Education Enforcement

Jackson Lewis P.C. on

The Department of Justice (DOJ) has initiated new, proactive civil-rights investigations into the admissions practices of certain medical schools, marking a significant expansion of federal oversight into graduate and...more

Vorys, Sater, Seymour and Pease LLP

The Price Is Wrong: Dominated PPOs and the Downfall of ERISA Settlor Discretion

A recent decision from the Northern District of Illinois threatens to expose health and welfare plan fiduciaries to the same types of imprudent selection claims that have plagued defined contribution plans for more than two...more

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Key Provisions of the Remedy Act and Their Impact on Hatch‑Waxman Litigation

In the United States, both patent law and U.S. Food and Drug Administration (FDA) regulations govern the commercial availability of drug products and any potential periods of market exclusivity....more

Robins Kaplan LLP

Corcept Therapeutics, Inc. v. Teva Pharms. USA, Inc.

Robins Kaplan LLP on

Corcept owns the patents-in-suit, which claim methods of coadministering mifepristone with a strong CYP3A inhibitor (e.g., ketoconazole) to treat Cushing's syndrome, a disorder that causes excessive cortisol production....more

Bass, Berry & Sims PLC

ERISA Preemption – Alive and Well

Bass, Berry & Sims PLC on

The recent rise in state law regulation of pharmacy benefit managers (PBMs) and prescription drug pricing continues to test the limits of preemption under the Employee Retirement Income Security Act of 1974, as amended...more

Hinshaw & Culbertson - Privacy, Cyber & AI...

6 Key Takeaways From the IAPP 2026 Global Summit for Privacy Compliance Professionals

The International Association of Privacy Professionals’ (IAPP) 2026 Global Summit brought together regulators, in‑house counsel, privacy officers, and technologists to discuss a complete spectrum of modern privacy issues....more

Bass, Berry & Sims PLC

FinCEN Advisory Warns Financial Institutions of Healthcare Fraud Targeting Medicare and Medicaid

Bass, Berry & Sims PLC on

At the end of March, the U.S. Treasury Department’s Financial Crimes Enforcement Network (FinCEN) issued a new Advisory urging financial institutions to heighten scrutiny of transactions potentially tied to healthcare fraud...more

Jones Day

A Tough Dose: 100% Tariffs Target Foreign-Manufactured Brand-Name Pharmaceuticals

Jones Day on

The Trump administration has moved to impose a 100% tariff on imports of brand-name, patented pharmaceutical products and ingredients, while extending lower rates for jurisdictions that have entered into bilateral agreements...more

Womble Bond Dickinson

FDA’s 2026 General Wellness Policy and What It Means for Manufacturers of Wearable Devices

Womble Bond Dickinson on

Wearable devices are products worn on the body that use sensors and software to collect and display health or lifestyle information such as activity, sleep, or recovery trends. Wearable technology has advanced quickly. Many...more

Hogan Lovells

New Blanche memo confirms shift in fraud crackdown: What the new National Fraud Enforcement Division means for business

Hogan Lovells on

On April 7, 2026, Acting Attorney General Todd Blanche issued a memorandum formally establishing the National Fraud Enforcement Division (NFED), in the most significant restructuring of the Department of Justice's (DOJ or...more

Foster Garvey PC

Canada’s New Front-of-Package Nutrition Labeling Rules Now in Effect

Foster Garvey PC on

On January 1, 2026, the new requirements of the front-of-package (FOP) nutrition labeling program initiated by Health Canada and enforced by the Canadian Food Inspection Agency (CFIA) took effect. These regulations were...more

Cozen O'Connor

Massachusetts AG Pushes New Guardrails for Assisted Living Residences

Cozen O'Connor on

Massachusetts AG Andrea Joy Campbell announced draft regulations defining specific unfair or deceptive acts within assisted living residences under the state’s consumer protection law. Among other requirements, the draft...more

Amundsen Davis LLC

Trump Overhauls Section 232 Tariffs on Patented Pharmaceutical Products

Amundsen Davis LLC on

On April 2, 2026, President Trump issued a proclamation under section 232 tariff authority imposing sweeping new tariffs on patented pharmaceutical products and ingredients imported into the U.S., with rates reaching up to...more

Brownstein Hyatt Farber Schreck

FDA FY ’27 Budget Proposes Broad New Authorities and Reforms Across Food, Drugs and Medical Devices

The Food and Drug Administration (FDA)’s FY 2027 budget proposal, which is the first fully developed under Commissioner Marty Makary’s tenure, includes a wide-ranging collection of legislative proposals that aim to expand the...more

Mintz - Health Care Viewpoints

States Continue to Advance New PBM and Drug Pricing Legislation in 2026

While federal and state legislators contemplate the next wave of PBM and drug pricing reform, legislatures in Virginia and Ohio have already sent significant legislation addressing prescription drug pricing and pharmacy...more

ArentFox Schiff

A Hard Pill to Swallow: 100% Tariffs Hit Pharma

ArentFox Schiff on

While Section 232 tariffs have so far been largely a metals-and-autos story, pharma has now officially joined the narrative....more

Foley & Lardner LLP

Structuring Discounts Arrangements in Compliance with Federal Anti-Kickback Law: OIG's Advisory Opinion 25-11

Foley & Lardner LLP on

Offering discounts on pricing of medical products is often proposed as an advantageous business strategy in the health care industry. While offering discounts is a longstanding and common practice, if structured improperly,...more

Foley & Lardner LLP

Hemp Product Use in Medicare: CMS Greenlights Pilot Program under the Substance Access Beneficiary Engagement Incentive

Foley & Lardner LLP on

On April 1, 2026, the Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center (CMMI), officially launched a new pilot program which allows participants in specific CMS programs to offer eligible hemp...more

Cadwalader, Wickersham & Taft LLP

The New Fraud Enforcement Division Takes Shape: DOJ Announces Restructuring and Reallocation of Resources to Support the Division

On April 7, 2026, the Department of Justice (“DOJ”) announced plans to consolidate and realign resources to staff the National Fraud Enforcement Division (the “Fraud Division”) that was created by President Trump in January...more

Foley Hoag LLP

2026 White Collar Year in Preview

Foley Hoag LLP on

The 2026 White Collar Year in Preview ebook provides a comprehensive analysis of anticipated enforcement trends and legal developments across key areas of white collar law. As the federal government continues to advance its...more

Arnall Golden Gregory LLP

Florida Memory Care License Law for Assisted Living Facilities: Compliance and Investment Implications

Key Takeaways - Florida is formalizing memory care regulation for assisted living facilities (“ALFs”). A new specialty license for memory care services, administered by the Agency for Health Care Administration (“AHCA”), will...more

61,902 Results
 / 
View per page
Page: of 2,477

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide